Histone deacetylase as target for antiprotozoal agents
US6110697A · kind A · utility
29Cited by
3References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 20, 1996 |
| Grant date | Aug 29, 2000 |
| Priority date | — |
| Expiry date | Sep 20, 2016 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Histone deacetylase inhibition provides a target for identifying potential antiprotozoal compounds. Histone deacetylase inhibitors are useful as therapeutic agents against protozoal infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.